Insider · CIK 0001874021
Kanesa-thasan Niranjan
Reports to the SEC for 1 company · SEATTLE, WA
Transactions
34
Companies
1
Filings
5
CIK
0001874021
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-02-19 | Icosavax, Inc.U Disposition from Tender | — |
| 2024-02-19 | Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2023-12-20 | Icosavax, Inc.S Sale | −$184K |
| 2023-07-31 | Icosavax, Inc.S Sale | −$29.4K |
| 2023-02-15 | Icosavax, Inc.Stock Option (Right to Buy)A Award | — |
| 2023-02-13 | Icosavax, Inc.S Sale | −$19.2K |
| 2023-01-04 | Icosavax, Inc.Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2023-01-04 | Icosavax, Inc.M Exercise/Conversion | +$11.6K |
| 2023-01-04 | Icosavax, Inc.M Exercise/Conversion | +$89.6K |
| 2023-01-04 | Icosavax, Inc.S Sale | −$1.67M |
| 2023-01-04 | Icosavax, Inc.Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2023-01-04 | Icosavax, Inc.Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2023-01-04 | Icosavax, Inc.Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2023-01-04 | Icosavax, Inc.M Exercise/Conversion | +$77.6K |
| 2023-01-04 | Icosavax, Inc.M Exercise/Conversion | +$70.5K |
| 2022-11-10 | Icosavax, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-08-02 | Icosavax, Inc.S Sale | −$3,640.163 |
| 2022-08-01 | Icosavax, Inc.S Sale | −$13.3K |
| 2022-07-29 | Icosavax, Inc.S Sale | −$4,982.428 |
| 2022-05-31 | Icosavax, Inc.A Award | +$9,618.59 |
| 2022-02-10 | Icosavax, Inc.Stock OptionA Award | — |
| 2022-02-10 | Icosavax, Inc.A Award | — |
| 2022-02-02 | Icosavax, Inc.Stock Option Right to Buy)M Exercise/Conversion | — |
| 2022-02-02 | Icosavax, Inc.Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-02-02 | Icosavax, Inc.M Exercise/Conversion | +$40.5K |
| 2022-02-02 | Icosavax, Inc.M Exercise/Conversion | +$11.6K |
| 2021-08-02 | Icosavax, Inc.P Purchase | +$100K |
| 2021-07-30 | Icosavax, Inc.A Award | +$623K |
Recent filings
- 4Kanesa-thasan Niranjan0000950170-24-017399SEC(opens sec.gov)
- 4Kanesa-thasan Niranjan0001209191-24-001074SEC(opens sec.gov)
- 4Kanesa-thasan Niranjan0001209191-23-059621SEC(opens sec.gov)
- 4Kanesa-thasan Niranjan0001209191-23-044090SEC(opens sec.gov)
- 4Kanesa-thasan Niranjan0001209191-23-010910SEC(opens sec.gov)
Companies
Address
C/O ICOSAVAX, INC. 1616 EASTLAKE AVENUE E., SUITE 208
SEATTLE, WA, 98102-3793